Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102)
Cat.#: ACPP-1102
Specifications
Despition Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) for ELISA, SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence EPHA3 (Glu21-Gln541) + mFc (Pro99-Lys330) + 6×His Tag Molecular Weight 85.9 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Mouse Fc Tag and 6×His Tag Applications ELISA, SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1041 Recombinant Human Wnt3a Protein (AC1041) 50 µg inquiry ACPP-1368 KCNJ2 Blocking Peptide (AC1368) 250 µg inquiry ACPP-1607 Mouse Leptin Protein, PEG (AC1607) 20 µg inquiry ACPP-1106 Recombinant Human c-Kit Protein (6×His Tag) (AC1106) 50 µg inquiry ACPP-1253 Pin1 Blocking Peptide (AC1253) 250 µg inquiry ACPP-1310 SHC Blocking Peptide (AC1310) 250 µg inquiry ACPP-1265 EDG8 Blocking Peptide (AC1265) 250 µg inquiry ACPP-1758 Human GMFB Protein (AC1758) 2 µg inquiry ACPP-1160 Recombinant Human GPCR GPR20 Protein (Fc Tag) (AC1160) 50 µg inquiry ACPP-1526 Human KCTD11 Protein (AC1526) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket